Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 10/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 7/20 | 0.46 |
| ▸ | PSMB5 | P28074 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.36 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7957017 | 0.93 | PTGIR (0.48) | PTGIRTBXA2RPSMB5PTGER1PTGER4 | |
| SCHEMBL7958426 | 0.92 | PTGIR (0.47) | PTGIRTBXA2RPSMB5 | |
| SCHEMBL7958406 | 0.85 | PTGIR (0.56) | PTGIRTBXA2RPSMB5 | |
| SCHEMBL7958534 | 0.84 | PTGIR (0.56) | PTGIRTBXA2RPSMB5 | |
| SCHEMBL7960382 | 0.84 | PTGIR (0.47) | PTGIRTBXA2RPSMB5SLC6A4SLC6A3 | |
| SCHEMBL7948961 | 0.82 | PTGIR (0.46) | PTGIRTBXA2RPSMB5 | |
| SCHEMBL7958938 | 0.82 | PTGIR (0.69) | PTGIRTBXA2RPSMB5 | |
| SCHEMBL7957079 | 0.81 | PTGIR (0.46) | PTGIRTBXA2RPSMB5 | |
| SCHEMBL7960033 | 0.76 | PTGIR (0.64) | PTGIRTBXA2RPSMB5 | |
| SCHEMBL7948871 | 0.73 | PTGIR (0.61) | PTGIRTBXA2RPSMB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6323235-B1 | CARDIOVASCULAR DISORDERS, ANTIISCHEMIC AGENTS AND ENZYME INHIBITORS | OHTAKE ATSUSHI (JP) | 2001-11-27 | — | — | US | disclosed |
| US-6043264-A | A THROMBOXANE A2 RECEPTOR ANTAGONIST FOR TREATING HYPERTENSION, THROMBOSIS, ISCHEMIC HEART DISEASES, CIRCULATORY DISEASES, ARTERIOSCLEROSIS, PLATELET FUNCTION DISORDER, HYPERLIPIDEMIA, NEPHRITIS OR ASTHMA | TORAY INDUSTRIES, INC. (JP) | 2000-03-28 | — | — | US | disclosed |
| EP-0751126-A1 | BENZENE-FUSED HETEROCYCLIC DERIVATIVE AND USE OF THE SAME | TORAY INDUSTRIES, INC. (JP) | 1997-01-02 | — | — | EP | disclosed |